T&D Diagnostics, headquartered in Canada with a manufacturing unit in the Netherlands, recently updated its plans to manufacture more products in India.
T&D entered into a strategic partnership with Genenest – A Noida-based biotech company to manufacture its Fluorescence Immunoassay Analyzer (FIA) range in India. Under this strategic partnership, Genenest will be the exclusive manufacturer in India for T&D’s StarkWert range of FIA products that are gaining rapid popularity in India.
StarkWert is a Fluorescence Immunoassay Analyzer which works based on the detection of fluorescence emitted during an immunoassay with antigen antibody interaction.
Manish Varma, CEO of T&D Diagnostics Canada, the parent company of T&D Diagnostics India and T&D Diagnostics Europe shared his vision of making India hub to serve international markets, especially Asian markets. Depending on various regulatory approvals, T&D can introduce IVD kits manufactured in India to different countries.
Varma said, "Global supply chains including manufacturing and distribution hubs that conform to stringent quality control norms would form the basis of any IVD company with global aspirations. Gone are the times, when a single country’s base could serve internationally. We have seen the supply disruptions during times of COVID-19 and with potential tariff war coming up, we can see organisations with multinational operations having an advantage in terms of seamless supply maintaining the same quality by replicating the standards, thus leading to the same customer experiences over and over again. This in the long run creates a high brand equity, something every successful company pursues."
